Shanghai Hutchison Pharmaceuticals Limited
Clinical trials sponsored by Shanghai Hutchison Pharmaceuticals Limited, explained in plain language.
-
New stroke drug shows promise in early trial
Disease control CompletedThis study tested a new medicine called SHPL-49 given as an IV for 7 days to people who had a stroke caused by a blood clot. The goal was to see if it helps them recover better and is safe. 270 adults aged 18-80 took part in this Phase 2 trial.
Phase: PHASE2 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Herbal pill shows promise for neck nerve pain in new trial
Symptom relief CompletedThis study tested a Chinese herbal pill called Shenqi Sherong in 428 adults with mild to moderate cervical spondylotic myelopathy, a condition where the spinal cord in the neck is compressed. The goal was to see if the pill improves movement, sensation, and daily function better …
Phase: PHASE3 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Symptom relief
Last updated May 17, 2026 11:20 UTC